|

Lysogenic HSV virus. Clinical Trials

1 actively recruiting trial

▼ -1 trial since June 2026

Also known as: Biological agent

Pipeline

Phase 1: 1

Top Sponsors

  • West China Hospital1

Indications

  • Lysogenic HSV Virus1
  • Targeted Therapy1
  • HNSCC1
  • Immunotherapy1
  • Neoadjuvant Therapy1

Other1 trial

A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.